Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2000
11/08/2000EP1049777A1 Acpl dna and polypeptides
11/08/2000EP1049776A1 Phagocytosis genes and uses thereof
11/08/2000EP1049775A1 Human btrcp protein
11/08/2000EP1049718A1 Monoclonal antibody anti alphav-integrin and its use to inhibit alphavbeta6-integrin attachment to fibronectin
11/08/2000EP1049717A2 Antibodies against human il-12
11/08/2000EP1049490A2 Method for inhibiting cd95-independent apoptosis in aids
11/08/2000EP1049465A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
11/08/2000EP0687180B1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
11/08/2000EP0636029B1 Antibodies specific for carcinoma-associated antigens
11/08/2000EP0635132B1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
11/08/2000CN1272886A Polynucleotide encoding polypeptide having heparanase activity and expression of same in transduced cells
11/08/2000CN1272884A Adipocyte-specific protein homologs
11/08/2000CN1272883A Adipocyte-specific protein homologs
11/08/2000CN1272760A Hypersensitive response elicitor from i (erwinia amylovora), its use and encoding gene
11/08/2000CN1272547A Human prenylation Rab conjugated protein and its coded sequence
11/08/2000CN1272545A Human neurogenic glutamine transport protein and its coded sequence
11/08/2000CN1272544A Human bladder protein and its coded sequence
11/08/2000CN1272543A Human gene expression regulatory factor related protein and its coded sequence
11/08/2000CN1272542A Human protein phosphoglycan protein and its coded sequence
11/08/2000CN1272541A Human trans-Golgi network protein isomer and its coded sequence
11/08/2000CN1272540A Human immune factor related protein and its coded sequence
11/08/2000CN1272539A Human cytodiaeresis inhibition factor protein and its coded sequence
11/08/2000CN1058296C Antibody heteroconjugates for use in regulation lymphocyte activity
11/07/2000US6143950 Plant steroid 5α reductase, DET2
11/07/2000US6143876 Immunogenic antigenic epitope which is a member of a binding couple; for production of antibodies with increased affinity; diagnosis; treatment; vaccines; viricides against human immunodeficiency virus
11/07/2000US6143875 Antibody to DNase involved in apoptosis
11/07/2000US6143873 Monoclonal anti-multiple drug resistance antibody, methods of production and uses thereof
11/07/2000US6143872 Polypeptide encoded by dna having defined nucleotide sequence; early diagnosis of lyme disease using polymerase chain reaction primers; vaccines
11/07/2000US6143869 CD30 ligand oligomers and polypeptides
11/07/2000US6143867 Amino acid sequence; for diagnosis, prevention, and treatment of late-phase allergic/inflammatory reactions, eosinophilias, parasitic infections, conditions associated with placental derived-basic protein accumulation in pregnancy
11/07/2000US6143865 Amino acid sequences which are reactive with viral antibodies; for accurate and sensitive immunoassay diagnosis
11/07/2000US6143720 Lipocalin homologs
11/07/2000US6143559 Antibodies against mammalian antigens with highly conserved epitopes by cloning and manipulation of immunoglobulin genes
11/07/2000US6143544 Human lysophospholipase
11/07/2000US6143543 Nucleotide sequence coding a hydrolase; for use in food processing
11/07/2000US6143537 Reducing proteins susceptibility to degradation; mixing protein and immunoglobulin in solution, detecting degradation reducing complex
11/07/2000US6143521 Human bombesin receptor subtype-3sb
11/07/2000US6143511 Contacting nonhydrolyzed body fluid sample with first and second antibodies to form complex, detecting presence or amount of complex, wherein antibodies bind to telopeptide having sequence identical to that produced in vivo
11/07/2000US6143509 Prostate specific antigen peptides and uses thereof
11/07/2000US6143505 Determining presence of invasive cells in tumor tissue by detecting presence of laminin 5 gamma-2 chain protein, comprising contacting tissue with antibody which specifically binds to said chain, detecting immunocomplex formed
11/07/2000US6143498 Antimicrobial peptide
11/07/2000US6143493 HCMV-specific peptides, agents therefor and the use thereof
11/07/2000US6143330 Compositions for inhibiting dental caries and/or middle ear infections and uses thereof
11/07/2000US6143297 Immunizing a mammals; forming antibodies
11/07/2000US6143296 Antibody 67D2
11/07/2000US6143273 Useful as immunosuppressants, as well as antibodies capable of preventing the specific binding of the lag-3 protein to major histocompatibility complex class ii molecules as immunostimulants
11/07/2000CA2166981C Oncoprotein protein kinase
11/07/2000CA2024767C Interferon-gamma receptor fragment and its production
11/02/2000WO2000065340A1 Protein-protein interactions
11/02/2000WO2000065089A1 tktA
11/02/2000WO2000065071A1 Nucleic acid molecule, containing a nucleic acid which codes for a polypeptide with chorismate mutase activity
11/02/2000WO2000065069A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000WO2000065068A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000WO2000065057A1 Inhibition of viral infection using monovalent antigen-binding proteins
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065046A1 Pollinosis-associated gene 373
11/02/2000WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000WO2000064946A2 Compositions and methods for cancer treatment by selectively inhibiting vegf
11/02/2000WO2000064938A2 Peptide homodimers or peptide heterodimers derived from interleukin 12
11/02/2000WO2000064936A2 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2
11/02/2000WO2000064489A2 Diagnostic marker for the human heart
11/02/2000WO2000064488A2 Somatic transgene immunization and related methods
11/02/2000WO2000064482A1 Nerve cell growth modulators (amphibodies)
11/02/2000WO2000064480A1 Treatment, imaging and diagnosis of disease using an agent which binds alfa5-integrin
11/02/2000WO2000064479A1 Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders
11/02/2000WO2000064475A1 Treatment of metastatic cancer through mts-1 gene
11/02/2000WO2000064474A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
11/02/2000WO2000064473A1 Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins
11/02/2000WO2000064469A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
11/02/2000WO2000064465A1 Death domain containing receptors
11/02/2000WO2000064327A2 Inhibition of complement action
11/02/2000WO2000064261A1 Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof
11/02/2000WO2000041516A3 Reagents and methods useful for detecting diseases of the breast
11/02/2000WO2000041508A3 Combination therapy of cancer by the activation of co-stimulatory molecules expressed by immune cells and cytokines
11/02/2000WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
11/02/2000WO2000039136A3 Human brainiac-5
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000WO2000037640A9 Compositions and methods for the treatment of tumor
11/02/2000WO2000037504A9 Human monoclonal antibodies to ctla-4
11/02/2000WO2000029029A9 Compositions and methods for producing vascular occlusion
11/02/2000WO2000024873A9 Process for recovering heterologous polypeptides from bacterial cells
11/02/2000WO2000008173A9 Identification and functional characterization of a novel ribosomal s6 protein kinase
11/02/2000WO2000006592A9 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
11/02/2000EP1048734A2 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
11/02/2000EP1048728A1 Means and method for the prevention and or treatment of trypanosomosis
11/02/2000EP1048299A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/02/2000EP1047944A1 Immunoassay for detection of very low density lipoprotein and antibodies useful therefor
11/02/2000EP1047942A1 Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
11/02/2000EP1047788A2 Metastatic breast and colon cancer regulated genes
11/02/2000EP1047787A1 Human calcineurin b-like protein
11/02/2000EP1047784A2 Neissera meningitidis antigens
11/02/2000EP1047782A1 Interleukin-1 receptor antagonist beta (il-1ra beta)
11/02/2000EP1047780A1 Orphan receptors
11/02/2000EP1047777A2 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
11/02/2000EP1047776A2 Therapeutic composition comprising the kal protein and use of the kal protein
11/02/2000EP1047775A1 Hematopoietic signaling factor
11/02/2000EP1047770A1 Histidine kinase
11/02/2000EP1047711A1 Nucleic acid sequences encoding capsaicin receptors
11/02/2000EP1047456A1 A method and composition for cancer treatment by enzymatic conversion of soluble radioactive toxic agents
11/02/2000EP1047301A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
1 ... 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 ... 1494